Publication | Closed Access

A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children

VaccinationVaccine SafetyDose-range StudyVaccine DevelopmentMedicineImmunologyVaccine EfficacyYoung ChildrenInfection ControlSecond YearVaccine Research